An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart ...

Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...

Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...

When a patient has an inherited cancer-associated gene, it is desirable — but not easy — to have other family members tested. In the United States, the difficulty primarily stems from privacy ...

Colorectal cancer is officially the leading cause of cancer-related death among younger men, according to a January report by the American Cancer Society. It is also the second leading cause for women ...

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and a future of more precise, patient-centered care.